The suit alleges that several prominent doctors, including the clinical research director of the prestigious Cleveland Clinic, were involved in helping promote the use of Rapamune.
The suit describes a speakers list of 18 physicians who could talk about off-label use of drugs. One of those cited was the Cleveland Clinic's Dr. Stuart Flechner, who was available to speak about the use of Rapamune "for an honorarium of $2,000 or "prorated $15,000." Flechner, a fellow of the American College of Surgeons, was named one of the Top Doctors in America, according to the clinic's Website.
When doctors at Mt. Sinai Medical Center expressed concerns about using Rapamune as part of a specific regimen, Wyeth brought in Flechner to talk to them:

"Wyeth paid Dr. Flechner to assist in the marketing of the unapproved combination of Cellcept, an IL-2 receptor antagonist and Rapamune in order to overcome these objections and secure Rapamune sales."
In addition to the lawsuit, federal prosecutors have opened a criminal investigation into Wyeth's promotion and marketing of Rapamune. Pfizer, in a regulatory filing on February 26, announced that it was under investigation by the U.S. Attorney's office for the Western District of Oklahoma. A spokesman for the Cleveland Clinic was not able to provide a comment in time for publication.
 
We were told by one of the nurses there that an African American gentlemen who was a kidney transplant patient was given Rappamune and he developed a flesh eating disease and was rolled out with a sheet over his head in the middle of the night. It is a proven fact that Rappamune is not to be given to African Americans because of their strong immune system, it can be fatal to them. Another experiment gone bad. They could care less that it was a human life. 

Do you want your family members experimented on with drugs the Cleveland Clinic are paid to use? There are  cases that have come to our attention where transplant patients of 20 years of more are being taken off their current immunopressant drugs and put on the drugs that are new. They are losing their kidneys. It is stated that it is unsafe to change your kidney medications and start over with new ones. And the reasoning behind this? There is no money to be made on the old medicines, and the drug companies make it worth their while for the Cleveland Clinic to experiment with these new drugs on their patients. All roads lead back to money, not respect for humanity.